Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Synthon Holdings BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013341
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon Holdings BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Synthon Acquires LEX System From Biolex Therapeutics 11
Partnerships 13
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Licensing Agreements 17
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Asset Transactions 21
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Acquisition 22
Synthon Acquires Syntarga 22
Synthon Holdings BV – Key Competitors 24
Synthon Holdings BV – Key Employees 25
Synthon Holdings BV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Clinical Trials 28
May 18, 2016: Synthon advances clinical evaluation of anti-HER2 ADC SYD985 in an expanded cohort of HER2-positive metastatic breast cancer patients 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Synthon Holdings BV, Pharmaceuticals & Healthcare, Key Facts 2
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Acquires LEX System From Biolex Therapeutics 11
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Synthon Acquires Syntarga 22
Synthon Holdings BV, Key Competitors 24
Synthon Holdings BV, Key Employees 25
Synthon Holdings BV, Subsidiaries 26

★海外企業調査レポート[Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise value hearing health, biomedical solutions, hearing health manufacturing and professional audio. In addition it also …
  • Can-Fite BioPharma Ltd (CANF)-製薬・医療分野:企業M&A・提携分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi pro …
  • Ciena Corp (CIEN):企業の財務・戦略的SWOT分析
    Ciena Corp (CIEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Inova Health System:企業の戦略的SWOT分析
    Inova Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Crowley Maritime Corp:企業の戦略的SWOT分析
    Crowley Maritime Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fujita Kanko Inc:企業の戦略・SWOT・財務情報
    Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report Summary Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EMS SA:企業の戦略的SWOT分析
    EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Storm Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Storm Therapeutics Ltd (Storm Therapeutics) a spin-out of University of Cambridge is focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer and other diseases. The company is engaged in modulating RNA modifying enzymes and is developing a unique …
  • Vivartia Holdings SA.:企業の戦略的SWOT分析
    Vivartia Holdings SA. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Intermountain Healthcare Inc-医療機器分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Team Health Holdings Inc (TMH):企業の財務・戦略的SWOT分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care and healthcare services. The organization’s services include hospital medicine, emergency medicine, anesthesiology, hospital medicine subspecialties, ambulatory care, post-acute care, and behavioral h …
  • Safaricom Ltd
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hasbro, Inc. (HAS):企業の財務・戦略的SWOT分析
    Hasbro, Inc. (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Rural Bank Limited:企業の戦略・SWOT・財務分析
    Rural Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Rural Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Daiichi Sankyo Inc-製薬・医療分野:企業M&A・提携分析
    Summary Daiichi Sankyo Inc (Daiichi Sankyo), a subsidiary of Daiichi Sankyo Company Ltd is a healthcare products provider that discovers and develops medicines for cardiovascular and metabolic disorders. The company's products comprise amlodipine, laninamivir, prasugrel, olmesartan esomeprazole, car …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, perinatology, urology and electrosurgery, respiratory and OEM products. Its blood pressure monitor …
  • Alcami Corp:企業の戦略的SWOT分析
    Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cemat AS (CEMAT):企業の財務・戦略的SWOT分析
    Cemat AS (CEMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sungrow Power Supply Co Ltd (300274):企業の財務・戦略的SWOT分析
    Summary Sungrow Power Supply Co Ltd (Sungrow) is a renewable energy company that manufactures power supply equipment for solar PV and wind power projects. The company's products include central inverter, string inverter, storage systems and accessories. It offers services such as construction, devel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆